MAI Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

MAI Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-20,000	Closed	-$2.18K	–	1137
2023 Q1	$2.18K	Hold	20,000	–	–	﹤0.01%	1041
2022 Q4	$1.05K	Hold	20,000	–	–	﹤0.01%	1015
2022 Q3	$24K	Hold	20,000	–	–	﹤0.01%	914
2022 Q2	$36K	Hold	20,000	–	–	﹤0.01%	852
2022 Q1	$40K	Hold	20,000	–	–	﹤0.01%	884
2021 Q4	$54K	Buy	20,000 +10,000	+100%	+$37K	﹤0.01%	874
2021 Q3	$45K	Hold	10,000	–	–	﹤0.01%	776
2021 Q2	$58K	Hold	10,000	–	–	﹤0.01%	748
2021 Q1	$70K	Buy	+10,000	New	+$67K	﹤0.01%	702

MAI Capital Management's CLVS Position: Q2 2023 in Review

MAI Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q2 2023, closing a stake of 20,000 shares — an estimated $2.18K sold.

MAI Capital Management first reported a position in CLVS in Q1 2021 and held it in 9 quarters. The position peaked at $70K in Q1 2021. 0 funds tracked by Wall St. Rank hold CLVS as of Q2 2023.

MAI Capital Management reported no remaining Clovis Oncology, Inc. position as of Q2 2023 after selling out during the quarter.
MAI Capital Management sold 20,000 Clovis Oncology, Inc. shares in Q2 2023, an estimated $2.18K.
MAI Capital Management first reported a position in Clovis Oncology, Inc. in Q1 2021 and held it in 9 quarters.
MAI Capital Management's Clovis Oncology, Inc. position peaked at $70K in Q1 2021.
0 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2023.

Based on MAI Capital Management's 13F filing for Q2 2023, filed 2 Aug 2023.